Hanson & Doremus Investment Management - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hanson & Doremus Investment Management ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$28,000
-51.7%
5150.0%0.01%
-50.0%
Q4 2015$58,000
-4.9%
5150.0%0.03%
-10.3%
Q3 2015$61,000
+52.5%
5150.0%0.03%
+70.6%
Q2 2015$40,000
+33.3%
5150.0%0.02%
+30.8%
Q1 2015$30,000
+76.5%
5150.0%0.01%
+85.7%
Q4 2014$17,000
+30.8%
5150.0%0.01%
+16.7%
Q3 2014$13,000
+44.4%
5150.0%0.01%
+50.0%
Q2 2014$9,0005150.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 5,621,423$59,700,00036.62%
VHCP Management, LLC 1,610,856$17,107,0009.45%
Broadfin Capital, LLC 1,737,669$18,454,0003.28%
Consonance Capital Management LP 737,685$7,834,0001.96%
Palo Alto Investors LP 1,600,178$16,994,0001.78%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 520,091$5,523,0001.06%
QVT Financial LP 1,358,303$14,425,0000.98%
Lombard Odier Asset Management (USA) Corp 1,700,000$18,054,0000.91%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,702,300$18,061,0000.89%
Perceptive Advisors 1,947,736$20,684,0000.85%
View complete list of ANACOR PHARMACEUTICALS INC shareholders